Deep Track Capital, LP - 18 Feb 2025 SCHEDULE 13D/A Report for Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX)

Filing manager: Deep Track Capital, LP
Reporting owner: Deep Track Biotechnology Master Fund, Ltd.
Security: Dynavax Technologies Corporation Common Stock, par value $0.001 per share
Beneficially owned shares: 17,791,486 shares
Large-stake signal: Form
SCHEDULE 13D/A
Active or control-oriented beneficial ownership filing.
Ownership
14%
Beneficial ownership of this reported class.
Shares
17,791,486 shares
Shares beneficially owned as disclosed.
Event date
18 Feb 2025
Date tied to the ownership event or amendment.
Accepted by SEC
19 Feb 2025
EDGAR acceptance date.
How to read this large-stake filing
Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
Compare this filing with the holder history and issuer page before treating the percentage as a current position.
Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
Class ownership: 14%
Symbol: DVAX
Shares outstanding: 131,788,785 shares
SEC form: SCHEDULE 13D/A
Accepted by SEC: 19 Feb 2025, 21:51:40 UTC
Event date: 18 Feb 2025
Next SEC filing: 25 Aug 2025
Source filing: View source filing

Key filing fact

Deep Track Capital, LP disclosed 14% ownership in Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX) on 18 Feb 2025.

Key facts

Deep Track Capital, LP filed SCHEDULE 13D/A for Dynavax Technologies Corporation Common Stock, par value $0.001 per share (DVAX).
Disclosed ownership: 14%.
Date of event: 18 Feb 2025.

This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

Reporting persons

Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name	Ownership	Shares owned	Shared voting power	Signature	Title	CIK
Deep Track Biotechnology Master Fund, Ltd.	14%	17,791,486	17,791,486	/s/ David Kroin	David Kroin, Director	0002015536
Deep Track Capital, LP	14%	17,791,486	17,791,486	/s/ David Kroin	David Kroin, Managing Member of the General Partner of Deep Track Capital, LP	0001856083
David Kroin	14%	17,791,486	17,791,486	/s/ David Kroin	David Kroin	0001397513

CIK / CUSIP context first

Broader feeds